A carregar...
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...
Na minha lista:
| Publicado no: | Crit Care |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/ https://ncbi.nlm.nih.gov/pubmed/27659071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|